Literature DB >> 18003638

High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project.

Norihiro Kato1, Toshiyuki Miyata, Yasuharu Tabara, Tomohiro Katsuya, Kazuyuki Yanai, Hironori Hanada, Kei Kamide, Jun Nakura, Katsuhiko Kohara, Fumihiko Takeuchi, Hiroyuki Mano, Michio Yasunami, Akinori Kimura, Yoshikuni Kita, Hirotsugu Ueshima, Tomohiro Nakayama, Masayoshi Soma, Akira Hata, Akihiro Fujioka, Yuhei Kawano, Kazuwa Nakao, Akihiro Sekine, Teruhiko Yoshida, Yusuke Nakamura, Takao Saruta, Toshio Ogihara, Sumio Sugano, Tetsuro Miki, Hitonobu Tomoike.   

Abstract

Essential hypertension is one of the most common, complex diseases, of which considerable efforts have been made to unravel the pathophysiological mechanisms. Over the last decade, multiple genome-wide linkage analyses have been conducted using 300-900 microsatellite markers but no single study has yielded definitive evidence for 'principal' hypertension susceptibility gene(s). Here, we performed a three-tiered, high-density association study of hypertension, which has been recently made possible. For tier 1, we genotyped 80 795 SNPs distributed throughout the genome in 188 male hypertensive subjects and two general population control groups (752 subjects per group). For tier 2 (752 hypertensive and 752 normotensive subjects), we genotyped a panel of 2676 SNPs selected (odds ratio >or= 1.4 and P <or= 0.015 in tier 1) and identified 75 SNPs that showed similar tendency of association in tier 1 and tier 2 samples (P <or= 0.05 for allele frequency and P <or= 0.01 for genotype distribution tests). For tier 3 (619 hypertensive and 1406 normotensive subjects), we genotyped the 75 SNPs and found nine SNPs from seven genomic loci to be associated with hypertension (P <or= 0.05). In three of these loci, the lowest P-values were observed for rs3755351 (P = 1.7 x 10(-5)) in ADD2, rs3794260 (P = 0.0001) in KIAA0789 and rs1805762 (P = 0.0003) in M6PR when case-control comparison was made in the combined data. An SNP (rs3755351) within ADD2 had the lowest P-value and its experiment-wide significance level is 0.13. Thus, these results have nominated several susceptibility genes for hypertension, and independent replication will clarify their etiological relevance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003638     DOI: 10.1093/hmg/ddm335

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

Review 1.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 2.  Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation.

Authors:  Kenneth M Weiss
Journal:  Genetics       Date:  2008-08       Impact factor: 4.562

3.  Collapsing SNP genotypes in case-control genome-wide association studies increases the type I error rate and power.

Authors:  Abigail G Matthews; Chad Haynes; Chang Liu; Jurg Ott
Journal:  Stat Appl Genet Mol Biol       Date:  2008-07-25

4.  Implications of discoveries from genome-wide association studies in current cardiovascular practice.

Authors:  Panniyammakal Jeemon; Kerry Pettigrew; Christopher Sainsbury; Dorairaj Prabhakaran; Sandosh Padmanabhan
Journal:  World J Cardiol       Date:  2011-07-26

5.  The reference human genome demonstrates high risk of type 1 diabetes and other disorders.

Authors:  Rong Chen; Atul J Butte
Journal:  Pac Symp Biocomput       Date:  2011

6.  Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time.

Authors:  Erwin Reiling; Valeriya Lyssenko; Jolanda M A Boer; Sandra Imholz; W Monique M Verschuren; Bo Isomaa; Tiinamaija Tuomi; Leif Groop; Martijn E T Dollé
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

Review 7.  Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension.

Authors:  Georg B Ehret
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

8.  Effects of rare and common blood pressure gene variants on essential hypertension: results from the Family Blood Pressure Program, CLUE, and Atherosclerosis Risk in Communities studies.

Authors:  Khanh-Dung H Nguyen; Vasyl Pihur; Santhi K Ganesh; Ankit Rakha; Richard S Cooper; Steven C Hunt; Barry I Freedman; Joe Coresh; W H Linda Kao; Alanna C Morrison; Eric Boerwinkle; Georg B Ehret; Aravinda Chakravarti
Journal:  Circ Res       Date:  2012-11-12       Impact factor: 17.367

9.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.

Authors:  Christopher Newton-Cheh; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Kenneth D Bloch; Aarti Surti; Candace Guiducci; Sekar Kathiresan; Emelia J Benjamin; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Stefan Blankenberg; Frank Kee; Peter Nilsson; Xiaoyan Yin; Leena Peltonen; Erkki Vartiainen; Veikko Salomaa; Joel N Hirschhorn; Olle Melander; Thomas J Wang
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

10.  Genome-wide association studies of hypertension: light at the end of the tunnel.

Authors:  Claire E Hastie; Sandosh Padmanabhan; Anna F Dominiczak
Journal:  Int J Hypertens       Date:  2010-04-29       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.